Get the Stockscreener App
139.70
2.68%
-3.6408
Insulet Corp stock is traded at $139.70, with a volume of 1.24M.
It is down -2.68% in the last 24 hours and down -14.97% over the past month.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
See More
Previous Close:
$143.34
Open:
$141.32
24h Volume:
1.24M
Relative Volume:
0.80
Market Cap:
$9.69B
Revenue:
$2.90B
Net Income/Loss:
$302.80M
P/E Ratio:
32.51
EPS:
4.2965
Net Cash Flow:
$387.80M
1W Performance:
-2.34%
1M Performance:
-14.97%
6M Performance:
-43.37%
1Y Performance:
-56.58%
1-Day Range:
$138.28
$142.13
1-Week Range:
$138.28
$147.17
52-Week Range:
$126.40
$354.88
Insulet Corp Stock (PODD) Company Profile
Name
Insulet Corp
Sector
Industry
Phone
978-600-7000
Address
100 NAGOG PARK, ACTON, MA
Compare PODD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PODD
Insulet Corp
|
139.69 | 9.94B | 2.90B | 302.80M | 387.80M | 4.2965 |
ABT
Abbott Laboratories
|
110.06 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
332.34 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
90.64 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.56 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.78 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
Insulet Corp Stock (PODD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-24-26 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Apr-07-26 | Downgrade | Citigroup | Buy → Neutral |
| Jan-27-26 | Resumed | TD Cowen | Hold |
| Jan-12-26 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-16-25 | Initiated | Evercore ISI | Outperform |
| Nov-19-25 | Upgrade | UBS | Neutral → Buy |
| Oct-21-25 | Resumed | Stifel | Buy |
| Sep-08-25 | Resumed | Oppenheimer | Outperform |
| Jun-16-25 | Initiated | Truist | Buy |
| May-30-25 | Initiated | Goldman | Buy |
| May-13-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Apr-29-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-06-25 | Initiated | RBC Capital Mkts | Outperform |
| Nov-06-24 | Initiated | Bernstein | Outperform |
| May-30-24 | Initiated | Redburn Atlantic | Buy |
| May-07-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-02-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-21-23 | Upgrade | Citigroup | Neutral → Buy |
| Aug-21-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-26-23 | Initiated | Wolfe Research | Peer Perform |
| Nov-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-11-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-03-22 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-31-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-01-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Mar-19-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Jul-28-20 | Initiated | Wells Fargo | Overweight |
| Apr-24-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-03-20 | Initiated | BofA/Merrill | Neutral |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Dec-10-19 | Initiated | CFRA | Sell |
| Oct-23-19 | Initiated | Stifel | Hold |
| Oct-18-19 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-14-19 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-04-19 | Downgrade | UBS | Buy → Neutral |
| Oct-03-19 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-06-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Jun-10-19 | Downgrade | Northland Capital | Outperform → Market Perform |
| May-06-19 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-20-18 | Initiated | Berenberg | Buy |
| Feb-22-18 | Reiterated | Barclays | Overweight |
| Jan-08-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-03-17 | Upgrade | Canaccord Genuity | Hold → Buy |
| Sep-15-17 | Initiated | Barclays | Overweight |
View All
Insulet Corp Stock (PODD) Latest News
Why Insulet (PODD) Stock Is Down Today - Quiver Quantitative
OneDigital Investment Advisors LLC Buys Shares of 44,275 Insulet Corporation $PODD - MarketBeat
GSA Capital Partners LLP Acquires New Holdings in Insulet Corporation $PODD - MarketBeat
PODD UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Insulet (PODD) Investors of Securities Class Action Lawsuit Deadline on August 31, 2026 - TMX Newsfile
PODD FINAL DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Insulet Corporation ... - Caledonian Record
symbol__ Stock Quote Price and Forecast - CNN
Insulet (PODD) Q2 2026 Earnings Call Transcript - aol.com
Insulet Corp. stock outperforms competitors despite losses on the day - MarketWatch
Attention Long-Term Shareholders of ARS Pharmaceuticals, - GlobeNewswire
5 Must-Read Analyst Questions From Insulet’s Q2 Earnings Call - Yahoo Finance
PODD IMPORTANT DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Insulet Corporation ... - Caledonian Record
Contact Robbins LLP for Information About Leading the Lawsuit That Alleges Insulet Corporation ... - Caledonian Record
Important Notice to Long-Term Shareholders of Bloom Energy - GlobeNewswire
Insulet Corporation’s (PODD) Wearable Pod Tech Finds New Frontier - Yahoo Finance
Insulet Deadline: PODD Investors with Losses in Excess of $100K Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit - PR Newswire
Insulet Corporation (PODD) Stock Forecasts - Yahoo Finance
Insulet hires Pfizer alum Joan Campion to lead external comms - Medical Marketing and Media
PODD CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Insulet (P - The National Law Review
Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch
Insulet Corporation (PODD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Important Notice to Long-Term Shareholders of Erasca, Inc. - GlobeNewswire
Insulet Corporation (NASDAQ:PODD) Given Average Rating of "Hold" by Brokerages - MarketBeat
Insulet Corporation $PODD Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Insulet Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Bank of America Corp DE Sells 61,769 Shares of Insulet Corporation $PODD - marketbeat.com
Insulet (NASDAQ:PODD) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Beacon Investment Advisory Services Inc. Has $9.03 Million Stock Holdings in Insulet Corporation $PODD - MarketBeat
PODD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Insulet (PO - The National Law Review
PODD INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds - The National Law Review
PODD SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds In - The National Law Review
PODD Maintained by TD Cowen -- Price Target Lowered to $144 - GuruFocus
Insulet (PODD) Stock Looks Undervalued As The Market Stays Cautious - Yahoo Finance
Insulet (NASDAQ:PODD) Price Target Lowered to $144.00 at TD Cowen - MarketBeat
Insulet (NASDAQ:PODD) Price Target Lowered to $150.00 at UBS Group - MarketBeat
Insulet (NASDAQ:PODD) Given New $185.00 Price Target at Benchmark - MarketBeat
Insulet (NASDAQ:PODD) Price Target Lowered to $180.00 at Stifel Nicolaus - MarketBeat
FMR LLC (PODD) reports 964,296 Insulet Corp shares in amended 13G filing - Stock Titan
Raymond James cuts Insulet stock price target on type 2 attrition - Investing.com
PODD Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Insulet Corporation Securities LawsuitContact Levi & Korsinsky - Business Wire
Why is Insulet stock sliding today? - Investing.com
JPMorgan cuts Insulet to neutral on slowing U.S. growth, trims target by 45% - Yahoo! Finance Canada
Canaccord cuts Insulet stock price target to $179 on retention issues - Investing.com
Insulet (NASDAQ:PODD) Cut to Market Perform at Leerink Partners - marketbeat.com
Insulet (NASDAQ:PODD) Receives "Neutral" Rating from JPMorgan Chase & Co. - MarketBeat
Here Are Thursday’s Top Wall Street Analyst Research Calls: AppLovin, Charles River, Global Payments, HubSpot, Insulet Corporation, Roper Technologies, Sabra Health Care, Western Digital, Zillow Group, and More - 24/7 Wall St.
These Analysts Slash Their Forecasts On Insulet After Q2 Results - Benzinga
Wells Fargo cuts Insulet stock rating on attrition concerns - Investing.com
Insulet (PODD) Is Down 21.9% After Cutting 2026 Revenue Outlook On Weaker Type 2 Retention - Yahoo Finance
A Look at Insulet Corp (PODD) After 20.1% Decline -- GF Value $4 - GuruFocus
Insulet Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
Insulet Earnings: Solid Quarterly Results Give Way to Impending Deceleration in Second Half - Morningstar
Insulet Corp Stock (PODD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Insulet Corp Stock (PODD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BORIO LUCIANA | Director |
Jun 03 '26 |
Sale |
143.27 |
418 |
59,887 |
4,329 |
| WEATHERMAN ELIZABETH H | Director |
Jun 03 '26 |
Buy |
144.20 |
3,450 |
497,490 |
10,352 |
2.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):